Trial Profile
Comparison of Asthma-related Outcomes and Costs in Pediatric Subjects That Received Fluticasone Propionate, Budesonide or Montelukast in a Large Managed Care Population
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Budesonide (Primary) ; Fluticasone propionate (Primary) ; Montelukast (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GSK
- 10 Jul 2017 New trial record